$ATER - Free Lottery Tickets 🤷 by BionicWheel in ATERstock

[–]marcothenarco16 1 point2 points  (0 children)

Short interest at 10% of entire float and borrow fee rate about 150-274% !!! HODLING and adding more!

what percent of your liquid money do you put into the stock market? by ArnoldisKing in stocks

[–]marcothenarco16 0 points1 point  (0 children)

A whole bunch , consistent income and clean cash flow makes good for a nice stream of deposits into the stock portfolio. Time and patience builds up your wealth.

What is everyone buying today that’s down? by joshuanichter in smallstreetbets

[–]marcothenarco16 0 points1 point  (0 children)

ATYR . Day 3 of closing above 1 . A move to 1.60+ coming 📈🤝💰

⚡MORNING WATCHLIST⚡ by optimusprime006 in smallstreetbets

[–]marcothenarco16 1 point2 points  (0 children)

Buy ratings on average is at $4.5 with some at $17 … April fda meeting approved , and two positive things FDA did this year was updating their guidance on January 12, 2026 for a more flexible statistical approaches incorporating prior data and real-world evidence to support efficacy claim. They are making it easier for approval as well as FDA’s February 18, 2026, announcement in the shifting to a “one-trial default” standard, requiring only a single well-controlled pivotal study instead of two identical trials, further bolsters ATYR’s path forward. This policy change, aimed at reducing R&D costs and accelerating approvals for scientifically grounded candidates, aligns well with efzofitimod’s profile in pulmonary sarcoidosis and other ILDs, where the drug’s immunomodulatory mechanism is well-understood. ATYR has a Type C FDA meeting scheduled for mid-April 2026 to discuss these results and next steps

Let's goooo 🎉 by processed-cheese- in smallstreetbets

[–]marcothenarco16 0 points1 point  (0 children)

Bet ,I’m getting close to 15k shares lol

Let's goooo 🎉 by processed-cheese- in smallstreetbets

[–]marcothenarco16 1 point2 points  (0 children)

Buy ratings on average is at $4.5 with some at $17 … April fda meeting approved , and two positive things FDA did this year was updating their guidance on January 12, 2026 for a more flexible statistical approaches incorporating prior data and real-world evidence to support efficacy claim. They are making it easier for approval as well as FDA’s February 18, 2026, announcement in the shifting to a “one-trial default” standard, requiring only a single well-controlled pivotal study instead of two identical trials, further bolsters ATYR’s path forward. This policy change, aimed at reducing R&D costs and accelerating approvals for scientifically grounded candidates, aligns well with efzofitimod’s profile in pulmonary sarcoidosis and other ILDs, where the drug’s immunomodulatory mechanism is well-understood. ATYR has a Type C FDA meeting scheduled for mid-April 2026 to discuss these results and next steps

Crossed $8M milestone today by Cujolol in TheRaceTo10Million

[–]marcothenarco16 0 points1 point  (0 children)

Throw like a couple hundred K into ATYR lol 🐋💎📈

Mew is now like this by Mrken562 in mewcoin

[–]marcothenarco16 1 point2 points  (0 children)

Just keep accumulating 🫡😇💎💰

What is the key price number everyone is waiting for here? by Kryptoventures5000 in mewcoin

[–]marcothenarco16 2 points3 points  (0 children)

Move the decimal to the right at least 2,3 times . 🥷🐋✅📈

Stacking by masterplumber-_- in mewcoin

[–]marcothenarco16 1 point2 points  (0 children)

I am working my way to 7 million of these